Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H35O17.Cl |
| Molecular Weight | 691.031 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].COC1=CC(=CC(OC)=C1O)C2=C(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=C4C(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)=CC(O)=CC4=[O+]2
InChI
InChIKey=RHKJIVJBQJXLBY-FTIBDFQESA-N
InChI=1S/C29H34O17.ClH/c1-40-15-3-10(4-16(41-2)20(15)33)27-17(44-29-26(39)24(37)22(35)19(9-31)46-29)7-12-13(42-27)5-11(32)6-14(12)43-28-25(38)23(36)21(34)18(8-30)45-28;/h3-7,18-19,21-26,28-31,34-39H,8-9H2,1-2H3,(H-,32,33);1H/t18-,19-,21-,22-,23+,24+,25-,26-,28-,29-;/m1./s1
| Molecular Formula | C29H34O17 |
| Molecular Weight | 654.5701 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL261 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28445001 |
2.34 µM [IC50] | ||
Target ID: CHEMBL205 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28445001 |
99.0 µM [IC50] |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:49:27 GMT 2025
by
admin
on
Mon Mar 31 20:49:27 GMT 2025
|
| Record UNII |
I9I120531L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
240-785-9
Created by
admin on Mon Mar 31 20:49:27 GMT 2025 , Edited by admin on Mon Mar 31 20:49:27 GMT 2025
|
PRIMARY | |||
|
1309703
Created by
admin on Mon Mar 31 20:49:27 GMT 2025 , Edited by admin on Mon Mar 31 20:49:27 GMT 2025
|
PRIMARY | RxNorm | ||
|
MALVIN
Created by
admin on Mon Mar 31 20:49:27 GMT 2025 , Edited by admin on Mon Mar 31 20:49:27 GMT 2025
|
PRIMARY | |||
|
I9I120531L
Created by
admin on Mon Mar 31 20:49:27 GMT 2025 , Edited by admin on Mon Mar 31 20:49:27 GMT 2025
|
PRIMARY | |||
|
DTXSID80895052
Created by
admin on Mon Mar 31 20:49:27 GMT 2025 , Edited by admin on Mon Mar 31 20:49:27 GMT 2025
|
PRIMARY | |||
|
I9I120531L
Created by
admin on Mon Mar 31 20:49:27 GMT 2025 , Edited by admin on Mon Mar 31 20:49:27 GMT 2025
|
PRIMARY | |||
|
5319251
Created by
admin on Mon Mar 31 20:49:27 GMT 2025 , Edited by admin on Mon Mar 31 20:49:27 GMT 2025
|
PRIMARY | |||
|
407312
Created by
admin on Mon Mar 31 20:49:27 GMT 2025 , Edited by admin on Mon Mar 31 20:49:27 GMT 2025
|
PRIMARY | |||
|
16727-30-3
Created by
admin on Mon Mar 31 20:49:27 GMT 2025 , Edited by admin on Mon Mar 31 20:49:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |